Liraglutide 3.0 mg within a NHS Tier-3/4 weight management service results in similar weight loss compared to regulatory trials - The LIPOSAX first UK real-world evidence study
Keyword(s):
Keyword(s):
2018 ◽
Vol 14
(11)
◽
pp. S153
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 75
(OCE3)
◽
Keyword(s):